(R)-1-(1H-Benzo[d]imidazol-2-yl)ethan-1-amine

Catalog No. :
ACKOBG864
CAS No. :
163959-79-3
Molecular Formula :
C9H11N3
Molecular Weight :
161.21

IUPAC Name:(R)-1-(1H-benzo[d]imidazol-2-yl)ethan-1-amine

(R)-1-(1H-Benzo[d]imidazol-2-yl)ethan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$186.00Login to see priceInquiryInquiry
1g97%$332.00Login to see priceInquiryInquiry
5g97%$869.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-(1H-Benzo[d]imidazol-2-yl)ethan-1-amine
IUPAC Name(R)-1-(1H-benzo[d]imidazol-2-yl)ethan-1-amine
MDL No.MFCD16038110
Molecular FormulaC9H11N3
Molecular Weight161.21
SMILESC[C@@H](N)C1=NC2=CC=CC=C2N1
InChI KeyNXSULSSADMIWQD-ZCFIWIBFSA-N
Synonym(R)-1-(1H-Benzo[d]imidazol-2-yl)ethan-1-amine | (R)-(+)-2-(a-Methylmethanamine)-1H-benzimidazole | (R)-alpha-Methyl-1H-benzimidazole-2-methanamine | (1S)-1-(1H-1,3-benzodiazol-2-yl)ethan-1-amine | SCHEMBL8330903 | (R)-(+)-2-(-Methylmethanamine)-1H-benzimi
CAS No.163959-79-3
PubChem CID693233

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACKOBG864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACKOBG864 route product structure diagram
    ACKOBG864163959-79-3
Inquiry

2. ACKOBG864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKOBG864 route product structure diagram
    ACKOBG864163959-79-3
Inquiry

Comments (0)